. 2022 Oct 1;26(10):762–770. doi: 10.5152/AnatolJCardiol.2022.1787
Content of this journal is licensed under a Table 3.
Evaluation of Patient Groups According to The Severity of Hepatosteatosis
| Mild Steatosis (n = 24) | Severe Steatosis (n = 58) | P | |
|---|---|---|---|
| Age | 53.44 ± 11.67 | 57.46 ± 10.19 | .118 |
| Gender (F/M) | 30.52 ± 4.92 | 30.67 ± 5.11 | .899 |
| Total Cholesterol (mg/dL) | 13/12 | 22/36 | .134 |
| HDL Cholesterol (mg/dL) | 206.53 ± 34.9 | 198.38 ± 51.66 | .542 |
| LDL Cholesterol (mg/dL) | 45.97 ± 11.12 | 43.35 ± 11.31 | .410 |
| Triglyceride (mg/dL) | 131.03 ± 29.35 | 120.65 ± 42.59 | .349 |
| BMI (kg/m2) | 157.55 (57.55) | 144.5 (148) | .213 |
| HT (mm Hg) | 15 (60%) | 46 (79.3%) | .102 |
| CVD | 6 (24%) | 40 (68.9%) | <.001 |
| CVD family history | 12 (48%) | 38 (65.5%) | .150 |
| Liver attenuation (HU) | 54.72 ± 5.49 | 48.43 ± 8.1 | .001 |
| L/S ratio | 1.15 ± 0.3 | 0.95 ± 0.11 | <.001 |
| EAT volume (mm3) | 93.85 (43) | 112.11 (42) | .023 |
HDL, high-density lipoprotein; LDL, low-density lipoprotein; BMI, body mass index; HT, hypertension; CVD, cardiovascular disease; L/S, liver–spleen ratio; EAT volume, epicardial adipose tissue volume.